Tazid 250mg Injection contains an active component as Ceftazidime. It is an antibiotic medication that belongs to the class of drugs known as cephalosporins. This medication has a broad spectrum of activity against Gram-negative bacteria, including Pseudomonas aeruginosa, Klebsiella species, Escherichia coli, Proteus species, and many others. It is commonly used to treat various bacterial infections caused by susceptible organisms. It is used in treating lower respiratory tract infections, skin and skin structure infections, bone and joint infections, urinary tract infections, gynecologic infections, bacterial septicemia (bacterial infection entering the bloodstream), abdominal infections, and central nervous system infections caused by various strains of bacteria. This medicine can be combined with other antibiotics to create synergistic effects, enhancing the overall effectiveness of treatment in certain cases.

Individuals with a known allergy to cephalosporin antibiotics or penicillin antibiotics may have an increased risk of allergic reactions to Tazid 250mg Injection. It is primarily excreted through the kidneys. Patients with impaired kidney function may require dose adjustments or close monitoring to avoid potential side effects or toxicity. This can sometimes cause gastrointestinal disturbances such as diarrhea, colitis, or pseudomembranous colitis. Patients with a history of gastrointestinal diseases should be monitored closely while taking this medication. Some formulations of Tazid 250mg Injection may contain ingredients not recommended for use in newborns and infants. Always check with a pediatrician before administering any medication to young children.

Tazid 250mg Injection is used to treat the following:

• Respiratory tract infections
• Urinary tract infections
• Bone and joint infections
• Gynecologic infections
• Skin infections
• Abdominal infections
• Bacterial septicemia
• Infections in the nervous system

The therapeutic effect of Tazid 250mg Injection is its ability to effectively treat a wide range of serious bacterial infections, particularly those caused by Gram-negative bacteria. As a potent and broad-spectrum cephalosporin antibiotic, this medication works by inhibiting bacterial cell wall synthesis, leading to the destruction of susceptible bacteria. Its bactericidal action makes it a crucial choice in combating infections like complicated intra-abdominal infections, hospital-acquired pneumonia, bloodstream infections, urinary tract infections, and certain skin and soft tissue infections. Its intravenous formulation allows for rapid delivery and steady blood levels, making it well-suited for severe infections requiring immediate treatment. 

Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Tazid 250mg Injection, reducing effectiveness by causing undesirable side effects. 

• Store at room temperature, between 20°C to 25°C (68°F to 77°F).
• Keep away from moisture, heat, and light.
• It should not be frozen.
• Keep away from children and pets.

Tazid 250mg Injection is typically administered via injections in hospital settings by a healthcare professional. The dosage and frequency of administration depend on the severity of the infection, the patient's age, and kidney function.

Tazid 250mg Injection causes some side effects like all medications, although not everyone will experience them. 

Serious:

• Severe allergic reactions
• Severe skin reactions
• Clostridium difficile-associated diarrhea
• Liver problems (jaundice, dark urine, and persistent abdominal pain)
• Decreased urine output
• Swelling in the legs or ankles
• Changes in urination frequency

Common:

• Nausea
• Vomiting
• Diarrhea
• Rash
• Itching
• Pain or inflammation at the injection site (for intravenous use)
• Headache
• Fever

Patients with a history of allergies to cephalosporin or penicillin antibiotics should inform their healthcare provider to avoid potential allergic reactions. It is essential to complete the full course of treatment as prescribed, even if symptoms improve, to prevent antibiotic resistance. Tazid 250mg Injection can disrupt normal gut flora, leading to Clostridium difficile-associated diarrhea, so any signs of persistent diarrhea should be reported to the healthcare provider. Patients with impaired kidney or liver function may require dose adjustments or close monitoring. 

Since this medication can affect electrolyte levels, careful monitoring may be necessary, especially in high-risk patients. Use during pregnancy and breastfeeding requires careful evaluation by a healthcare professional to balance potential risks and benefits. Caution should be exercised in patients with central venous catheters to prevent catheter-related infections. Patients should promptly report any unusual or severe side effects to their healthcare provider.

1. KD Tripathi, Essentials of Medical Pharmacology, Beta-Lactam Antibiotics, 7th edition, 2013,728.
2. Goodman & Gilman’s, The Pharmacological Basics of Therapeutics, Penicillins, Cephalosporins and other Beta-Lactam Antibiotics, 12th edition, 2011, 1498.
3. B. Braun Medical Inc., US Food and Drug Administration, [Revised on October 2021] [ Accessed on 21st July 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/050823s009lbl.pdf.
4. Wockhardt UK Ltd, Electronic medicines compendium (EMC), [Revised on 16 Aug 2021] [ Accessed on 21st July 2023], https://www.medicines.org.uk/emc/files/pil.6346.pdf